GSK plc, a biotechnology company, reported that Japan's Ministry of Health, Labour and Welfare (MHLW) has endorsed Omjjara (momelotinib) for the treatment of myelofibrosis. Omjjara is an oral, once-daily inhibitor of JAK1/JAK2 and the activin A...
Roche, a leading biotechnology firm, declared the availability of its new analytical units, the cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions, in nations accepting the CE mark. The cobas c 703 and cobas ISE neo logical...
The International Society on Thrombosis and Haemostasis (ISTH), the most prominent international professional medical-scientific organization committed to improving the understanding, prevention, diagnosis, and treatment of thrombotic and...
Alivexis, Inc. furthermore, Melodia Therapeutics AG, an organization set up by Forty51 Endeavors, declared that they have forayed into an exclusive license agreement for the overall development, assembling, and commercialization of Alivexis...
Basilea Pharmaceutica Ltd., a commercial-stage biopharmaceutical firm with headquarters in Switzerland dedicated to treating patients with severe bacterial and fungal infections, declared that it has forayed into an asset purchase agreement...
Sanofi and Biovac, a Cape Town, South Africa-based biopharmaceutical business, have announced a local manufacturing agreement to produce inactivated polio vaccines (IPV) in Africa. This partnership aims to enable regional manufacturing of polio...
Sun Pharmaceutical Industries Limited stated that it has signed a non-exclusive patent licensing deal with Takeda Pharmaceutical Company Limited (Takeda) to market vonoprazan tablets 10 mg and 20 mg in India under the brand name "Voltapraz"...
Roche, a swiss based healthcare firm, declared the launch of the first clinically approved, highly sensitivity in-situ hybridisation (ISH) test, the VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay in nations embracing the CE Mark...
Aethlon Medical, Inc., a medical therapeutic company dedicated to creating products to treat cancer and life-threatening infectious illnesses, declared that the Human Research Ethics Committee (HREC) of the Central Adelaide Local Health Network...
Merck reported that the US Food and Drug Administration (FDA) has approved Keytruda, the company's anti-PD-1 medication, in combination with carboplatin and paclitaxel, followed by Keytruda as a single agent, for the treatment of adult patients...
, CDSCO.jpg)
